Pharmacovigilance news
AFI Symposium 2024: the latest from the pharmaceutical world
Discover the main themes of the AFI Symposium 2024, from sustainability to supply chain challenges, and explore the latest developments.
Pharmacovigilance news
Discover the main themes of the AFI Symposium 2024, from sustainability to supply chain challenges, and explore the latest developments.
The AFI Symposium 2024, held from June 5 to 7 in Rimini, offers a significant opportunity for professionals in the pharmaceutical sector to stay updated. Here are the sessions.
Clinical trials are a fundamental phase in the development of a therapy. We have gathered essential information worth knowing about them.
In a constant effort to promote awareness of the importance of this practice, we have collected and answered the most common questions relating to pharmacovigilance.
The new AIFA Board of Directors recently announced the allocation of funds for pharmacovigilance and cybersecurity.
There are numerous events that led to the birth of pharmacovigilance. Here is its evolution from its origins to today.
AIFA has recently embarked on a process of restructuring governance to promote investments in research and development and accelerate drug approval processes.
The latest edition of SD Collection, the SafetyDrugs special with insights, updates and useful advice on pharmacovigilance is now available.
The safety database is a fundamental tool for efficient pharmacovigilance ICSR management. Here are the main advantages of using it.
The ICSR transfer outside of EU entails risks in terms of compatibility between pharmacovigilance agreements and GDPR. Here's how be compliant.
Signal Management is the process of managing safety signals in pharmacovigilance. Here's what phases it consists of and how it is performed.
Signal Validation is the activity of verifying the reliability and completeness of the information supporting a potential signal. Here's how it's done according to GVP.
Signal Detection plays a fundamental role in the constant monitoring of the safety profile of a drug. Through this analysis it is possible to promptly identify possible signals of adverse effects associated with the use of a drug. Here's what Signal Detection is and how it's done.
Here are the best features to look for understand how to choose a safety database
A safety database is a fundamental tool for complying with pharmacovigilance regulations, allowing you to save time and resources. Here it is the reasons why a safety database is convenient for pharmaceutical companies.
The two Italian National Ethics Committees for clinical trials will evaluate the study protocols of their respective competencies on a monthly basis.
Citizens can now always be updated on any shortages of medicines thanks to AIFA Medicinali.
Medicinal products, although useful for the treatment of diseases that can afflict humans, are not free from possible risks and side effects. It is, therefore, necessary to constantly supervise the relationship between the expected benefit and the possibility and the degree of risk of each drug. Pharmacovigilance deals with this activity. Here is in detail what it is.